Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH

Enfermedades Infecciosas y Microbiologia Clinica - Tập 30 - Trang 22.e1-22.e23 - 2012
Jesús Rodríguez-Baño1, José Ramón Paño-Pardo2, Luis Alvarez-Rocha3, Ángel Asensio4, Esther Calbo5, Emilia Cercenado6, José Miguel Cisneros7, Javier Cobo8, Olga Delgado9, José Garnacho-Montero10, Santiago Grau11, Juan Pablo Horcajada12, Ana Hornero13, Javier Murillas-Angoiti14, Antonio Oliver15, Belén Padilla6, Juan Pasquau16, Miquel Pujol13, Patricia Ruiz-Garbajosa17, Rafael San Juan18
1Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Departamento de Medicina, Universidad de Sevilla, Sevilla, España
2Unidad de Enfermedades Infecciosas y Microbiología Clínica, Hospital Universitario La Paz-IDIPAZ, Madrid, España
3Servicio de Medicina Intensiva, Complexo Hospitalario Universitario de A’Coruña, A’Coruña, España
4Servicio de Medicina Preventiva, Hospital Puerta de Hierro, Madrid, España
5Servicio de Medicina Interna, Hospital Mutua de Terrasa, Terrasa, Barcelona, España
6Servicio de Microbiología y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid, España
7Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen del Rocío, Sevilla, España
8Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal-IRYCIS, Madrid, España
9Servicio de Farmacia Hospitalaria, Hospital Universitario Son Espases, Palma de Mallorca, España
10Servicio de Cuidados Críticos, Hospitales Universitarios Virgen del Rocío, Sevilla, España
11Servicio de Farmacia, Hospital Universitario del Mar, Barcelona, España
12Servicio de Medicina Interna-Enfermedades Infecciosas, Hospital Universitario del Mar, Barcelona, España
13Servicio de Enfermedades Infecciosas, Hospital Universitari de Bellvitge, Barcelona, España
14Servicio de Medicina Interna-Infecciosas, Hospital Universitario Son Espases, Palma de Mallorca, España
15Servicio de Microbiología, Hospital Universitario Son Espases, Palma de Mallorca, España
16Sección de Enfermedades Infecciosas, Hospital Universitario Virgen de las Nieves, Granada, España
17Servicio de Microbiología, Hospital Universitario Ramón y Cajal-IRYCIS, Madrid, España
18Sección de Enfermedades Infecciosas, Hospital Universitario 12 de Octubre, Madrid, España

Tài liệu tham khảo

Armstrong, 1999, Trends in infectious disease mortality in the United States during the 20th Century, JAMA, 281, 61, 10.1001/jama.281.1.61

Spellberg, 2008, The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America, Clin Infect Dis, 46, 155, 10.1086/524891

Kollef, 1999, Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients, Chest, 115, 462, 10.1378/chest.115.2.462

Kumar, 2006, Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock, Crit Care Med, 34, 1589, 10.1097/01.CCM.0000217961.75225.E9

Paul, 2010, Systematic review and meta-analysis of the efficacy of appropriate empirical antibiotic therapy for sepsis, Antimicrob Agents Chemother, 54, 4851, 10.1128/AAC.00627-10

Clatworthy, 2007, Targeting virulence: a new paradigm for antimicrobial therapy, Nat Chem Biol, 3, 541, 10.1038/nchembio.2007.24

Lipsitch, 2002, Antimicrobial use and antimicrobial resistance: a population perspective, Emerging Infect Dis, 8, 347, 10.3201/eid0804.010312

Martínez-Martínez, 2010, Development of resistance to antibiotic drugs: causes, consequences, and importance to the public health system, Enferm Infecc Microbiol Clin, 28, 4, 10.1016/S0213-005X(10)70035-5

Boucher, 2009, Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America, Clin Infect Dis, 48, 1, 10.1086/595011

Vila, 2010, Prudent use of antibacterial agents: are we entering in an era of infections with no effective antibacterial agents? What can we do?, Enferm Infecc Microbiol Clin, 28, 577, 10.1016/j.eimc.2010.09.002

European Center for Diseases Control. The bacterial Challenge: time to react. A call to narrow the gap between multidrug-resistant bacteria in the EU and the development of new antibacterial agents. 2009 [consultado 27 Nov 2010]. Disponible en: http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf

Livermore, 2009, Has the era of untreatable infections arrived?, J Antimicrob Chemother, 64, i29, 10.1093/jac/dkp255

Infectious Diseases Society of America, 2010, The 10 x ‘20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020, Clin Infect Dis, 50, 1081, 10.1086/652237

Center for Disease Control and Prevention. Get Smart: Know When Antibiotics Work [consultado 27 Nov 2010]. Disponible en: http://www.cdc.gov/getsmart/

Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Campaña Uso Prudente del Antibiótico [consultado 27 Nov 2010]. Disponible en: http://www.seimc.org/noticias/index.asp?apV=noticias&apV1=noticias&apnv0=noticias_usoprudenteantimicrobianos.htm

Infectious Diseases Society of America, 2011, (IDSA). Combating Antimicrobial Resistance: Policy Recommendations to Save Lives, Clin Infect Dis, 52, S397, 10.1093/cid/cir153

Infome EPINE (Estudio de Prevalencia de las Infecciones Nosocomiales en España). Sociedad Española de Medicina Preventiva Salud Pública e Higiene [consultado 11 Mar 2011]. Disponible en: http://www.sempsph.com. Last accessed: March 11th 2010.

Otero, 2006, Acontecimientos adversos prevenibles causados por medicamentos en pacientes hospitalizados, Med Clin (Barc), 126, 81, 10.1157/13083875

Shehab, 2008, Emergency department visits for antibiotic-associated adverse events, Clin Infect Dis, 47, 735, 10.1086/591126

John, 1997, Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital, Clin Infect Dis, 24, 471, 10.1093/clinids/24.3.471

Scheckler, 1970, Antibiotic usage in seven community hospitals, JAMA, 213, 264, 10.1001/jama.1970.03170280024004

Apisarnthanarak, 2006, Effectiveness of Education and an Antibiotic-Control Program in a Tertiary Care Hospital in Thailand, Clin Infect Dis, 42, 768, 10.1086/500325

Hecker, 2003, Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity, Arch Intern Med, 163, 972, 10.1001/archinte.163.8.972

Hulscher, 2010, Antibiotic prescribing in hospitals: a social and behavioural scientific approach, Lancet Infect Dis, 10, 167, 10.1016/S1473-3099(10)70027-X

Powers, 2009, Risk perception and inappropriate antimicrobial use: yes, it can hurt, Clin Infect Dis, 48, 1350, 10.1086/598184

Wikipedia contributors. Stewardship [Internet]. Wikipedia, The Free Encyclopedia [consultado 27 Nov 2010]. Disponible en: http://en.wikipedia.org/wiki/Stewardship

Dellit, 2007, Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship, Clin Infect Dis, 44, 159, 10.1086/510393

Almirante, 2010, Prudent use of antimicrobials. Have we done the best we can? The SEIMC and REIPI statement, Enferm Infecc Microbiol Clin, 28, 485, 10.1016/j.eimc.2010.07.008

MacDougall, 2005, Antimicrobial stewardship programs in health care systems, Clin Microbiol Rev, 18, 638, 10.1128/CMR.18.4.638-656.2005

MacKenzie, 2005, Report of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC), Clin Microbiol Infect, 11, 937, 10.1111/j.1469-0691.2005.01258.x

Patel, 2008, Antimicrobial stewardship programs: interventions and associated outcomes, Expert Rev Anti Infect Ther, 6, 209, 10.1586/14787210.6.2.209

Marwick, 2007, Quality of care in sepsis management: development and testing of measures for improvement, J Antimicrob Chemother, 60, 694, 10.1093/jac/dkm234

Fishman, 2006, Antimicrobial stewardship, Am J Med, 119, S53, 10.1016/j.amjmed.2006.04.003

Sourdeau, 2006, Implementation of antibiotic management teams in Belgian hospitals, Acta Clin Belg, 61, 58, 10.1179/acb.2006.011

Bantar, 2003, A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance, Clin Infect Dis, 37, 180, 10.1086/375818

Saizy-Callaert, 2003, Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital, J Hosp Infect, 53, 177, 10.1053/jhin.2002.1307

van Kasteren, 2000, [Optimizing antibiotics policy in the Netherlands VSWAB guidelines for perioperative antibiotic prophylaxis. Foundation Antibiotics Policy Team], Ned Tijdschr Geneeskd, 144, 2049

Bates, 1995, Incidence of adverse drug events and potential drug events. Implications for prevention, JAMA, 274, 29, 10.1001/jama.1995.03530010043033

Nolan, 2000, System changes to improve patient safety, Br Med J, 320, 771, 10.1136/bmj.320.7237.771

National Quality Forum. Safe Practices for Better Healthcare-2009 Update: A consensus report. Washington: NQF; 2003. p. 20096.

McGowan, 2004, Minimizing Antimicrobial Resistance: The Key Role of the Infectious Diseases Physician, Clin Infect Dis, 38, 939, 10.1086/382363

McQuillen, 2008, The value of Infectious Diseases Specialists: non-patient care activities, Clin Infect Dis, 47, 1051, 10.1086/592067

Power, 2006, Impact of antibiotic restrictions: the pharmaceutical perspective, Clin Microbiol Infect, 12, 25, 10.1111/j.1469-0691.2006.01528.x

Paterson, 2006, The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals, Clin Infect Dis, 42, S90, 10.1086/499407

Kollef, 2008, Broad-spectrum antimicrobials and the treatment of serious bacterial infection: getting it right up front, Clin Infect Dis, 47, S3, 10.1086/590061

Deresinski, 2007, Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data, Clin Infect Dis, 45, S177, 10.1086/519472

Delgado Sánchez, 2010, Uso prudente de antibióticos y propuestas de mejora desde la farmacia comunitaria y hospitalaria, Enferm Infecc Microbiol Clin, 28, 36, 10.1016/S0213-005X(10)70041-0

Rattanaumpawan, 2010, Effectiveness of drug use evaluation and antibiotic authorization on patients’ clinical outcomes, antibiotic consumption, and antibiotic expenditures, Am J Infect Control, 38, 38, 10.1016/j.ajic.2009.04.288

Ramsay, 2003, Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing, J Antimicrob Chemother, 52, 764, 10.1093/jac/dkg460

Vander Stichele, 2006, Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002), J Antimicrob Chemother, 58, 159, 10.1093/jac/dkl147

Polk, 2007, Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy, Clin Infect Dis, 44, 664, 10.1086/511640

Cantón, 2009, Consumo de antimicrobianos y resistencia en el hospital: una relación difícil de medir y compleja de interpretar, Enferm Infecc Microbiol Clin, 27, 437, 10.1016/j.eimc.2009.04.004

Baquero, 2001, Low-level antibacterial resistance: a gateway to clinical resistance, Drug Resist Update, 4, 93, 10.1054/drup.2001.0196

Cohen, 2008, Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper, Infect Control Hosp Epidemiol, 29, 901, 10.1086/591741

Cook, 2004, Reduction in broad-spectrum antimicrobial use associated with no improvement in human antibiogram, J Antimicrob Chemoter, 53, 853, 10.1093/jac/dkh163

Masterson, 1999, Antibiotic policies and the role of strategic hospital leadership, J Hosp Infect, 42, 261S, 10.1016/S0195-6701(99)90096-8

Davey, 2006, Systematic review of antimicrobial drug prescribing in hospitals, Emerg Infect Dis, 12, 211, 10.3201/eid1202.050145

Camins, 2009, The impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a Randomized controlled trial, Infect Control Hosp Epidemiol, 30, 931, 10.1086/605924

Paul, 2006, Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial, J Antimicrob Chemother, 58, 1238, 10.1093/jac/dkl372

Schwartz, 2009, Lost in translation? Reliability of assessing inpatient antimicrobial appropriateness with use of computerized case vignettes, Infect Control Hosp Epidemiol, 30, 163, 10.1086/593970

Lahey, 2009, Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia, Medicine, 88, 263, 10.1097/MD.0b013e3181b8fccb

Nagao, 2010, Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia, Clin Microbiol Infect, 16, 1783, 10.1111/j.1469-0691.2010.03156.x

Patel, 2005, Initial management of candidemia at an academic medical center: evaluation of the IDSA guidelines, Diagn Microbiol Infect Dis, 52, 29, 10.1016/j.diagmicrobio.2004.12.010

Byl, 1999, Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia, Clin Infect Dis, 29, 60, 10.1086/520182

Girardis, 2009, Effects on management and outcome of severe sepsis and septic shock in patients admitted to the intensive care unit after implementation of a sepsis program: a pilot study, Crit Care, 13, R143, 10.1186/cc8029

Nathwani, 2002, Quality indicators for antibiotic control programmes, J Hosp Infect, 50, 165, 10.1053/jhin.2001.1171

WHO Global Strategy for Antimicrobial Resistance Containment ‘consultado 7 Ene 2011]. Disponible en: http://www.who.int/drugresistance/WHO_Global_Strategy_English.pdf

Sbarbaro, 2001, Can we influence prescribing patterns?, Clin Infect Dis, 33, S240, 10.1086/321856

Navarro C, Rodríguez-Baño J, Cobo J, de Gea-García JH, Vañó S, Moreno-Ramos F et al. Perceptions and knowledge about antimicrobial resistance among junior and senior residents of 5 Spanish hospitals. 21st European Conference of Clinical Microbiology and Infectious Diseases (ECCMID), P1279.

Davis, 1999, Impact of formal continuing medical education: do conferences, workshops, rounds and other continuing education activities change physician behaviour or health outcomes, JAMA, 282, 867, 10.1001/jama.282.9.867

Scwartzberg, 1997, Effect of training on physicians attitudes and practices in home and community care of the elderly, Arch Fam Med, 6, 439, 10.1001/archfami.6.5.439

PAUSE. Prudent Antibiotic User Web Page [consultado 28 Nov 2010]. Disponible en: http://www.pause-online.org.uk/

Pagani, 2009, Navigating the Web in search of resources on antimicrobial stewardship in health care institutions, Clin Infect Dis, 48, 626, 10.1086/596762

McGowan, 1974, Usage of antibiotics in a general hospital: effect of requiring justification, J Infect Dis, 130, 165, 10.1093/infdis/130.2.165

White, 1997, Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes, Clin Infect Dis, 25, 230, 10.1086/514545

Linkin, 2006, Inaccurate communications in telephone calls to an antimicrobial stewardship program, Infect Control Hosp Epidemiol, 27, 688, 10.1086/505918

LaRosa, 2007, Evaluation of antimicrobial therapy orders circumventing an antimicrobial stewardship program: investigating the strategy of “stealth dosing”, Infect Control Hosp Epidemiol, 28, 551, 10.1086/513535

Pestotnik, 2005, Expert clinical decision support systems to enhance antimicrobial stewardship programs: insights from the society of infectious diseases pharmacists, Pharmacotherapy, 25, 1116, 10.1592/phco.2005.25.8.1116

Buising, 2008, Electronic antibiotic stewardship--reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting, J Antimicrob Chemother, 62, 608, 10.1093/jac/dkn218

Agwu, 2008, A World Wide Web-based antimicrobial stewardship program improves efficiency, communication, and user satisfaction and reduces cost in a tertiary care pediatric medical center, Clin Infect Dis, 47, 747, 10.1086/591133

Connor, 2007, Impact of automatic orders to discontinue vancomycin therapy on vancomycin use in an antimicrobial stewardship program, Infect Control Hosp Epidemiol, 28, 1408, 10.1086/523864

Quale, 1996, Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci, Clin Infect Dis, 23, 1020, 10.1093/clinids/23.5.1020

Rahal, 1998, Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella, JAMA, 280, 1233, 10.1001/jama.280.14.1233

Peña, 1998, Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases, Antimicrob Agents Chemother, 42, 53, 10.1128/AAC.42.1.53

Burke, 1998, Antibiotic resistance--squeezing the balloon?, JAMA, 280, 1270, 10.1001/jama.280.14.1270

Toltzis, 1998, Antibiotic restriction does not alter endemic colonization with resistant gram-negative rods in a pediatric intensive care unit, Crit Care Med, 26, 1893, 10.1097/00003246-199811000-00035

Lautenbach, 2003, Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins, Clin Infect Dis, 36, 440, 10.1086/346153

Rahal, 2002, Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites, Clin Infect Dis, 34, 499, 10.1086/338639

Sanders, 1996, Cycling of antibiotics: an approach to circumvent resistance in specialized units of the hospital, Clin Microbiol Infect, 1, 223, 10.1016/S1198-743X(15)60278-6

Kollef, 2001, Is there a role for antibiotic cycling in the intensive care unit?, Crit Care Med, 29, N135, 10.1097/00003246-200104001-00014

Gerding, 1991, Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital, Antimicrob Agents Chemother, 35, 1284, 10.1128/AAC.35.7.1284

Dominguez, 2000, A pilot study of antibiotic cycling in a hematology-oncology unit, Infect Control Hosp Epidemiol, 21, S4, 10.1086/503166

Kollef, 1997, Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia, Am J Respir Crit Care Med, 156, 1040, 10.1164/ajrccm.156.4.9701046

Martínez, 2006, Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units, Crit Care Med, 34, 329, 10.1097/01.CCM.0000195010.63855.45

Kollef, 2006, Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?, Clin Infect Dis, 43, S82, 10.1086/504484

McCabe, 2009, Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rule, Arch Intern Med, 169, 1525, 10.1001/archinternmed.2009.259

Arnold, 2009, Community-Acquired Pneumonia Organization (CAPO) Investigators. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-acquired Pneumonia Organization International cohort study results, Arch Intern Med, 169, 1515, 10.1001/archinternmed.2009.265

Bodí, 2005, Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival, Clin Infect Dis, 41, 1709, 10.1086/498119

Frei, 2010, Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit, Clin Ther, 32, 293, 10.1016/j.clinthera.2010.02.006

Kett, 2011, Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study, Lancet Infect Dis, 11, 181, 10.1016/S1473-3099(10)70314-5

Ochoa, 2002, Diseño y evaluación de protocolos clínicos, Nuevo Hospital, 2, 1

Ibrahim, 2001, Experience with a clinical guideline for the treatment of ventilator-associated pneumonia, Crit Care Med, 29, 1109, 10.1097/00003246-200106000-00003

Dellit, 2008, Development of a guideline for the management of ventilator-associated pneumonia based on local microbiologic findings and impact of the guideline on antimicrobial use practices, Infect Control Hosp Epidemiol, 29, 525, 10.1086/588160

Miliani, 2009, Non-compliance with recommendations for the practice of antibiotic prophylaxis and risk of surgical site infection: results of a multilevel analysis from the INCISO Surveillance Network, J Antimicrob Chemother, 64, 1307, 10.1093/jac/dkp367

Rioux, 2007, Impact of a six-year control programme on surgical site infections in France: results of the INCISO surveillance, J Hosp Infect, 66, 217, 10.1016/j.jhin.2007.04.005

Carratalá J, Navas E, San Juan R, Soriano F, Rodríguez V. Guía de recomendaciones en la terapia secuencial antibiótica (TSA). Guías clínicas SEIMC 2006 [consultado 13 Feb 2011]. Disponible en: http://www.seimc.org/documentos/guias/2006/Guia3_2006_TS.A.pdf

Cobo Reinoso, 2002, Evaluación de un programa de asesoramiento en tratamiento antibiótico, Rev Clin Esp, 202, 78, 10.1016/S0014-2565(02)70989-2

Lopez-Medrano, 2005, PACTA: efecto de un programa no impositivo de control y asesoramiento del tratamiento antibiótico sobre la disminución de los costes y el descenso de ciertas infecciones nosocomiales, Enferm Infecc Microbiol Clin, 23, 186, 10.1157/13073141

Fraser, 1997, Antibiotic optimization. An evaluation of patient safety and economic outcomes, Arch Intern Med, 157, 1689, 10.1001/archinte.1997.00440360105012

Briceland, 1988, Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach, Arch Intern Med, 148, 2019, 10.1001/archinte.1988.00380090091022

Rüttimann, 2004, Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital, Clin Infect Dis, 38, 348, 10.1086/380964

Jenkins, 2008, Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia, Clin Infect Dis, 46, 1000, 10.1086/529190

Rieg, 2009, Mortality of Staphylococcus aureus bacteremia and infectious diseases specialist consultation: a study of 521 patients in Germany, J Infect, 59, 232, 10.1016/j.jinf.2009.07.015

Sutepvarnon, 2008, Inappropriate use of antifungal medications in a tertiary care center in Thailand: a prospective study, Infect Control Hosp Epidemiol, 29, 370, 10.1086/587633

Uçkay, 2009, Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unit, J Infect, 58, 205, 10.1016/j.jinf.2009.01.012

Diamantis, 2010, Evaluation of initial antibiotic therapy for bacteremia and role of an antibiotic management team for antibiotic stewardship, Med Mal Infect, 40, 637, 10.1016/j.medmal.2010.06.002

Scheetz, 2009, Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis, J Antimicrob Chemother, 63, 816, 10.1093/jac/dkp004

Rodríguez-Baño, 2010, Current management of bloodstream infections, Expert Rev Anti Infect Ther, 8, 815, 10.1586/eri.10.49

Evans, 1998, A computer-assisted management program for antibiotics and other antiinfective agents, N Engl J Med, 338, 232, 10.1056/NEJM199801223380406

Kawamoto, 2005, Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success, Br Med J, 330, 765, 10.1136/bmj.38398.500764.8F

Thursky, 2006, Use of computerized decision support systems to improve antibiotic prescribing, Expert Rev Anti Infect Ther, 4, 491, 10.1586/14787210.4.3.491

Clinical Laboratory Standards Institute, 2011

European Committee for Antimicrobial Susceptibility, Testing. EUCAST Definitive Document E. DEF 2. 1, August 2000: Breakpoint tables for interpretation of MICs and zone diameters. Version 1. 3 [consultado 20 Abr 2011]. Disponible en: http://www.eucast.org 2011.

Alós, 2010, ¿Qué antibióticos debemos informar en el antibiograma y cómo?, Enferm Infecc Microbiol Clin, 28, 737, 10.1016/j.eimc.2010.05.003

Wolk, 2009, Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares, J Clin Microbiol, 47, 758, 10.1128/JCM.01714-08

Garnacho-Montero, 2003, Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis, Crit Care Med, 31, 2742, 10.1097/01.CCM.0000098031.24329.10

Garnacho-Montero, 2008, Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU by sepsis: a matched cohort study, J Antimicrob Chemother, 61, 436, 10.1093/jac/dkm460

Heffner, 2010, Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department, Clin Infect Dis, 50, 814, 10.1086/650580

Pulcini, 2006, Factors associated with adherence to infectious diseases advice in two intensive care units, J Antimicrob Chemother, 57, 546, 10.1093/jac/dki483

Micek, 2006, Before-after study of a standardized hospital order set for the management of septic shock, Crit Care Med, 34, 2707, 10.1097/01.CCM.0000241151.25426.D7

Ferrer, 2008, Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain, JAMA, 299, 2294, 10.1001/jama.299.19.2294

Eachempati, 2009, Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?, J Trauma, 66, 1343, 10.1097/TA.0b013e31819dca4e

Rello, 2004, De-escalation therapy in ventilator-associated pneumonia, Crit Care Med, 32, 2183, 10.1097/01.CCM.0000145997.10438.28

Gruson, 2003, Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia, Crit Care Med, 31, 1908, 10.1097/01.CCM.0000069729.06687.DE

Raineri, 2010, Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria, Eur J Clin Microbiol Infect Dis, 29, 1015, 10.1007/s10096-010-0964-5

Merz, 2006, The impact of an antibiotic cycling program on empirical therapy for gram-negative infections, Chest, 130, 1672, 10.1378/chest.130.6.1672

Bates, 1995, Incidence of adverse drug events and potential drug events. Implications for prevention, JAMA, 274, 29, 10.1001/jama.1995.03530010043033

National Qualty Forum. Safe Practices for Better Healthcare-2009 Update: A consensus report. Washington, DC: NQF; 20096. 2003.

Baquero, 2010, Prudent use of antimicrobial agents: revisiting concepts and estimating perspectives in a global world, Enferm Infecc Microbiol Clin, 28, 487, 10.1016/j.eimc.2010.07.009

Ansari, 2003, Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis, J Antimicrob Chemother, 52, 842, 10.1093/jac/dkg459